FDA seeks input on addressing patient-level data challenges for RWD/RWE

The US Food and Drug Administration (FDA) is requesting feedback on possible solutions that would help sponsors more effectively submit patient-level real-world data (RWD) and real-world evidence (RWE) for drug and biological product applications.